IRIS
ALONCI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.036
NA - Nord America 4.277
AS - Asia 2.369
SA - Sud America 905
AF - Africa 67
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.182
RU - Federazione Russa 2.506
SG - Singapore 1.097
BR - Brasile 787
CN - Cina 629
IE - Irlanda 622
SE - Svezia 595
HK - Hong Kong 281
DE - Germania 269
UA - Ucraina 233
IT - Italia 217
FR - Francia 157
GB - Regno Unito 151
FI - Finlandia 137
VN - Vietnam 113
IN - India 54
CA - Canada 49
AR - Argentina 45
PL - Polonia 40
MX - Messico 32
TR - Turchia 29
BD - Bangladesh 27
EC - Ecuador 24
AT - Austria 22
BE - Belgio 22
ZA - Sudafrica 20
NL - Olanda 18
JP - Giappone 17
ES - Italia 16
PK - Pakistan 16
IQ - Iraq 15
IR - Iran 14
UZ - Uzbekistan 14
MA - Marocco 13
ID - Indonesia 11
VE - Venezuela 11
CO - Colombia 10
KE - Kenya 9
CL - Cile 8
PE - Perù 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CZ - Repubblica Ceca 6
EG - Egitto 6
JO - Giordania 5
PY - Paraguay 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
AZ - Azerbaigian 3
CH - Svizzera 3
DZ - Algeria 3
IL - Israele 3
KG - Kirghizistan 3
MY - Malesia 3
NO - Norvegia 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
RO - Romania 3
SA - Arabia Saudita 3
SN - Senegal 3
SY - Repubblica araba siriana 3
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
GR - Grecia 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MN - Mongolia 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 12.663
Salva come PNG Salva come JPEG
Città #
Moscow 723
Dublin 622
Singapore 575
Chandler 562
Ashburn 502
Jacksonville 451
Dallas 365
Nyköping 298
Beijing 283
Hong Kong 281
The Dalles 157
San Jose 150
Dearborn 122
Princeton 109
Cambridge 106
Medford 106
Lauterbourg 99
Messina 98
Los Angeles 92
Ann Arbor 90
Des Moines 90
New York 77
Boardman 76
São Paulo 65
Munich 62
Buffalo 51
Woodbridge 46
Warsaw 35
Tianjin 34
Ho Chi Minh City 33
Wilmington 29
Frankfurt am Main 28
Hanoi 27
Belo Horizonte 25
Orem 23
Brussels 22
Lancaster 22
Redondo Beach 22
Guangzhou 21
Turku 19
Vienna 19
Shenyang 18
Montreal 17
Tokyo 17
London 16
Nanjing 16
Rio de Janeiro 16
San Mateo 16
Chennai 15
Hebei 15
Jinan 15
Johannesburg 15
Porto Alegre 14
Brasília 13
Tashkent 13
Helsinki 12
Houston 12
Quito 12
Recife 12
Rome 12
Seattle 12
Poplar 11
Santa Clara 11
Bremen 10
Palermo 10
Pune 10
Shanghai 10
Stockholm 10
Atlanta 9
Auburn Hills 9
Düsseldorf 9
Chicago 8
Council Bluffs 8
Denver 8
Hangzhou 8
Lahore 8
Manchester 8
Milan 8
Nairobi 8
Ningbo 8
Washington 8
Curitiba 7
Fortaleza 7
Phoenix 7
Reggio Calabria 7
Ribeirão Preto 7
Salvador 7
San Francisco 7
Strasbourg 7
São José dos Campos 7
Zhengzhou 7
Amsterdam 6
Ardabil 6
Augusta 6
Bauru 6
Boston 6
Changsha 6
Dong Ket 6
Istanbul 6
Lanzhou 6
Totale 7.208
Salva come PNG Salva come JPEG
Nome #
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 251
Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws 210
Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura 206
E rosette formation in B cell chronic lymphocytic leukemia. 201
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 198
Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombocythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders 196
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies 186
Circulating microRNAs: New biomarkers in diagnosis, prognosis and treatment of cancer (Review). 183
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and n two relatives with lymphoproliferative disorders 182
Novel therapeutic strategies in multiple myeloma: role of the heat shock protein inhibitors 181
Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer. 179
Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia. 173
ABERRANT EXPRESSION OF CANCER TESTIS ANTIGENS IN HEMATOLOGIC MALIGNANCIES 172
Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates 172
L'ipersplenismo: attualità e prospettive future 171
Beta 2 microglobulina ed emopatie maligne 167
Angiogenesis in patients with biphosphonate-associated osteonecrosis of the jaw 166
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 165
Assenza della mutazione JAK2 V617F nel compartimento linfoide di un paziente affetto da trombocitemia essenziale e leucemia linfatica cronica a cellule B ed in due parenti affetti da disordini linfoproliferativi 161
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 158
Circulating endothelial progenitor cells and angiogenic serum factors in patients with chronic myeloproliferative diseases 157
Serum levels of interleukin-16 in lymphoid malignancies. 155
Circulating levels of intercellular adhesion Molecule-1 (ICAM-1) and soluble Interleukin 2 receptors(IL-2R) in patients with B cell Chronic Lynphocityc Leukemia 153
Carbonyl groups serum levels are associated with CD38 expression in patients with B chronic lymphocytic leucemia. 150
Angiogenesis in patients with bisphosphonate-associated osteonecrosis of the jaw. 149
MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma 149
Association of osteonecrosis of the jaws and POEMS syndrome in a patient assuming rituximab. 149
Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients. 147
The cancer stem cell hypothesis: a guide to potential molecular targets. 146
Immunohistochemical evaluation of sarcoglycans and integrins in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw. 145
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 145
Standardisation of minimal residual disease in multiple myeloma 145
Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1. 141
Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia 141
Decreased plasma levels of IL-33 could contribute to the altered function of Th2 Iymphocytes in patients with poIycythemia vera and essential thrombocythemia. 140
Possible role of Interleuki-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity 140
Cardiac involvement in patients with hematologic malignancies. 135
Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock 132
Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells 132
Immunohistochemical evaluation of sarcoglycans and integrin in gingival epithelium of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw 128
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC- LEUKEMIA 126
Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia 124
Lipid profile in hematologic neoplasms 121
Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia. 121
Prognostic value of serum thymidine kinase and beta 2 microglobulin in subjects affected by multiple myeloma 120
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response. 119
Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia. 116
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 113
Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions. 111
Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases. 105
Involvement of T2677T multidrug resistance gene polymorphism in Interleukin 22 plasma concentration in B-chronic lymphocytic leukemia patients. 104
Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases. 103
Increased serum levels of interleukin-31 could modulate inflammatory processes in multiple sclerosis 102
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma. 100
SOLUBLE ANGIOGENIC FACTORS: IMPLICATIONS FOR CHRONIC MYELOPROLIFERATIVE DISORDERS 98
Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. 98
JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. 98
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 97
Stevens-Johnson syndrome after lenalidomide therapy for multiple myeloma: a case report and a review of treatment options. 97
Elevated srum concentration of angiopoietin-2 in patients with multiple myeloma: correlation with markers of disease 95
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires”. 94
Screening dei deficit di G-6-PD in un campione di una popolazione scolastica 94
Reduced serum levels of interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration 92
MULTIDRUG RESISTANCE-1 GENE POLYMORPHISM ASSOCIATED WITH THE NEW MARKER OF DISEASE PROGRESSION AND POOR PROGNOSIS IN b-CELL CHRONIC LIMPHATIC LEUKEMIA 92
Serum levels of Interleukin-16 in a multiple myeloma patient with cutaneous involvement 92
Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602. 92
Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia 91
Prognostic significance of immunophenotype in chronic lymphocytic leukaemia 90
Serum levels of soluble ICAM-1 in patients with malignant lymphoma in association with treatment response 90
JAK2-Positive Latent Essential Thrombocythemia and Splanchnic Vein Thrombosis: The Role of Bone Marrow Biopsy for the Diagnosis of Myeloproliferative Disease. 88
Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. 88
POLYRADICOLONEUROPATHY AS A FORM OF RELAPSE IN A PATIENT WITH ACUTE MEGACARYOCYTIC LEUKAEMIA 87
SERUM LEVELS OF CD8-ANTIGEN AND SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA 87
Efficacia di Nilotinib in un giovane paziente affetto da LMC ad alto rischio Sokal in fallimento dopo inatinib ad alte dosi 87
EFFECTIVE THERAPY OF APLASTIC-ANEMIA POSTHEPATITIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN 86
Endothelial progenitor cells: pathogenetic role and therapeutic perspectives 85
Epigenetic therapy in myelodysplastic syndromes. 84
Soluble angiogenic factors: Implications for chronic myeloproliferative disorders 83
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. 83
Fludarabine based treatment caused improvement of anemia in a patient with T-cell LGL leukemia despite evidence of the persistence of the abnormal T-cell clone. 82
Increase of IL-17, IL-22 and IL-23 serum levels induced by immunoglobulin infusion for Parvovirus-B associated Pure Red Cell Aplasia in a renal transplant recipient. 82
Evaluation of circulating endothelial progenitor cells in patients with bisphosphonate-associated osteonecrosis of the jaw 82
METHYMAZOLE-INDUCED AGRANULOCYTOSIS AND QUICK RECOVERY WITH G-CSF: CARE REPORT 80
Imatinib mesylate treatment in a patient with chemoresistant Ph+ acute myeloid leukemia: possible role of Wilms' tumor gene 1. 80
Serum levels of interleukin-16 in a multiple myeloma patient with cutaneous involvement. 80
Increased levels of the soluble adhesion molecule E-selectin in patients with chronic myeloproliferative disorders and thromboembolic complications 79
Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia. 77
Nanoparticles in oncology: the new theragnostic molecules. 77
Reduction in IL–33 plasma levels might be involved in T–cell dysregulation in chronic lymphocytic leukemia. 77
Evaluation des sous-populations lymphocytaires chez des travailleurs exposés a basse dose du benzene. Données préliminaires 77
Significance of serum interleukin-16 levels in patients with B-cell chronic lymphocytic leukemia 76
Differential levels of soluble angiopèoietin-2 and Tie-2 in patients with haematological malignancies 76
Leukocyte integrin very late antigen-4/vascular cell adhesion molecule-1 adhesion pathway in splanchnic artery occlusion shock 76
Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera. 76
INTRACELLULAR AND SERUM LEVELS OF ALDOLASE ACTIVITY IN B- CHRONIC LYMPHOCYTIC-LEUKEMIA 73
Correlazione del polimorfismo genico di MDR-1 con i nuovi marcatori prognostici in pazienti affetti da Leucemia Linfatica Cronica a cellule B. 73
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B. 73
Differential levels of soluble angiopoietin-2 and Tie-2 in patients with haematological malignancies. 72
New orally active proteasome inhibitors in multiple myeloma. 72
Imatinib mesylate therapy induces reduction in neutrophil gelatinase-associated lipocalin serum levels and increase in leptin concentrations in chronic myeloid leukemia patients in molecular remission. 72
Totale 12.022
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.322
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.322
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021225 0 0 0 0 0 0 0 0 0 85 81 59
2021/2022641 5 57 14 20 18 8 40 26 13 89 98 253
2022/20231.944 164 168 82 174 165 199 17 110 775 9 58 23
2023/2024448 39 73 28 35 49 118 20 30 3 11 6 36
2024/20252.166 23 27 49 170 79 43 8 532 580 114 189 352
2025/20265.416 259 396 368 422 473 1.285 718 674 687 134 0 0
Totale 12.720